VBI Vaccines to Present at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference
20 juin 2019 08h00 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., June 20, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...